PURE · Pure Bioscience, Inc. · Shareholders & Ownership
Substantial doubt about the company's ability to continue as a going concern.
“Our history of recurring operating losses, and negative cash flows from operating activities give rise to substantial doubt regarding our ability to continue as a going concern.”View the 10-Q filed Jun 15, 2026
Every disclosed holder of PURE in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.
Who Owns PURE
13F quarter Sep 30, 2022| Holder group | Shares | % Out |
|---|---|---|
| Institutional (13F) | 809,809 | 0.62% |
| Insiders (Forms 3, 4, 5) | 12,998 | 0.01% |
| 13D/G-only blocks | 0 | 0.00% |
| Remaining | 129,194,762 | 99.37% |
| Registered funds (N-PORT, not summed) | 0 | 0.00% |
Shares outstanding: 130,017,569, the issuer's latest cover-page count restated onto today's split basis.
13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.
Holders of PURE
| # | Holder | Shares | As of | Notes |
|---|---|---|---|---|
| 1 |
IFG Advisory, LLC
13F
CIK 1728319 · Registered investment adviser · Sep 30, 2022
|
809,809 | ||
| 2 |
Kitchell Jeffrey Scott
Insider
CIK 2098340 · Nov 17, 2025
President, Corporate Secretary, issuer-wide
|
12,998 |
Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.